Ethnic and genetic determinants of omeprazole disposition and effect. (Q51580305)

7 April 2018

title

Ethnic and genetic determinants of omeprazole disposition and effect. (English)

1 reference

7 April 2018

1 reference

Caraco Y

1

1 reference

7 April 2018

Lagerstrom PO

series ordinal

2

1 reference

7 April 2018

Wood AJ

series ordinal

3

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 August 1996

1 reference

7 April 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

7 April 2018

volume

60

1 reference

7 April 2018

issue

2

1 reference

7 April 2018

page(s)

157-167

1 reference

7 April 2018

Distinct phenotypes and genotypes of debrisoquine hydroxylation among Europeans and Chinese

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Why are diazepam metabolism and polymorphic S-mephenytoin hydroxylation associated with each other in white and Korean populations but not in Chinese populations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Interphenotype differences in disposition and effect on gastrin levels of omeprazole—suitability of omeprazole as a probe for CYP2C19

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Influence of acid secretory status on absorption of omeprazole from enteric coated granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Ethnic differences in drug disposition and responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Interethnic variation of drug metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: polymorphism in RFLP and DNA sequence of CYP2D6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Dissociation of co-regulatory control of debrisoquin/phenformin and sparteine oxidation in Ghanaians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Diazepam metabolism in native Chinese poor and extensive hydroxylators of S-mephenytoin: interethnic differences in comparison with white subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Interethnic difference in omeprazole's inhibition of diazepam metabolism*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

The pharmacokinetics of omeprazole in humans--a study of single intravenous and oral doses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Omeprazole: pharmacokinetics and metabolism in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Effect of omeprazole on gastric acid secretion and plasma gastrin in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Production and evaluation of antibodies for the radioimmunoassay of gastrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Determination of omeprazole and metabolites in plasma and urine by liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Interethnic differences in omeprazole metabolism in the two S-mephenytoin hydroxylation phenotypes studied in Caucasians and Orientals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Appropriate acid suppression in the treatment of acid-related conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Optimizing acid suppression for treatment of acid-related diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Variability in individual response to various doses of omeprazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990131-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9236(96)90131-9

1 reference

7 April 2018

1 reference

7 April 2018